Medpace Holdings, Inc.
DE ˙ DB ˙ US58506Q1094
387,90 € ↑6,00 (1,57%)
2026-06-03
DEL PRIS
SecurityDE:01P / Medpace Holdings, Inc.
InstitutionBlackRock, Inc.
Latest Disclosed Ownership2,417,994 shares
Ownership 7.90%
BlackRock, Inc. ownership in 01P / Medpace Holdings, Inc.

2024-01-26 - BlackRock, Inc. has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,417,994 shares of Medpace Holdings, Inc. (DE:01P). This represents 7.9 percent ownership of the company. In their previous filing dated 2023-01-26 , BlackRock, Inc. had reported owning 3,163,001 shares, indicating a decrease of -23.55 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2024-01-26 2024-01-26 13G/A 3,163,001 2,417,994 -23.55 7.90 -22.55
2023-01-26 2023-01-26 13G/A 3,163,001 3,163,001 0.00 10.20 0.00
2023-01-20 2023-01-20 13G/A 3,757,573 3,163,001 -15.82 10.20 -2.86
2022-01-27 2022-01-27 13G/A 3,757,573 3,757,573 0.00 10.50 0.00
2022-01-26 2022-01-26 13G/A 3,791,168 3,757,573 -0.89 10.50 -0.94
2021-01-27 2021-01-27 13G/A 4,689,115 3,791,168 -19.15 10.60 -18.46
2021-01-27 2021-01-27 13G/A 3,791,168 3,791,168 0.00 10.60 0.00
2020-02-04 2020-02-04 13G/A 4,158,359 4,689,115 12.76 13.00 11.11
2019-01-11 2019-01-11 13G 4,158,359 11.70

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F MEDPACE HLDGS COM 58506Q109 2,470,440 57,823 2.40 1,186,281 -12.45 0.0207
2026-02-12 2025-12-31 13F MEDPACE HLDGS COM 58506Q109 2,412,617 55,494 2.35 1,355,046 11.81 0.0229
2025-11-12 2025-09-30 13F MEDPACE HLDGS COM 58506Q109 2,357,123 -107,567 -4.36 1,211,938 56.67 0.0212
2025-08-12 2025-06-30 13F MEDPACE HLDGS COM 58506Q109 2,464,690 -223,433 -8.31 773,568 -5.55 0.0147
2025-05-02 2025-03-31 13F MEDPACE HLDGS COM 58506Q109 2,688,123 -39,134 -1.43 819,044 -9.61 0.0172
2025-02-07 2024-12-31 13F MEDPACE HLDGS COM 58506Q109 2,727,257 40,695 1.51 906,077 1.04 0.0183
2024-11-13 2024-09-30 13F MEDPACE HLDGS COM 58506Q109 2,686,562 108,123 4.19 896,774 -15.55 0.0188
2024-08-13 2024-06-30 13F MEDPACE HLDGS COM 58506Q109 2,578,439 85,459 3.43 1,061,930 5.40 0.0240
2024-05-10 2024-03-31 13F MEDPACE HLDGS COM 58506Q109 2,492,980 74,924 3.10 1,007,538 35.93 0.0235
2024-02-13 2023-12-31 13F MEDPACE HLDGS COM 58506Q109 2,418,056 37,943 1.59 741,207 28.62 0.0189
2023-11-13 2023-09-30 13F MEDPACE HLDGS COM 58506Q109 2,380,113 -99,224 -4.00 576,297 -3.22 0.0166
2023-08-11 2023-06-30 13F MEDPACE HLDGS COM 58506Q109 2,479,337 -702,424 -22.08 595,462 -0.48 0.0164
2023-05-12 2023-03-31 13F MEDPACE HLDGS COM 58506Q109 3,181,761 18,630 0.59 598,330 -10.95 0.0176
2023-02-13 2022-12-31 13F MEDPACE HLDGS COM 58506Q109 3,163,131 136,113 4.50 671,881 41.22 0.0211
2022-11-14 2022-09-30 13F MEDPACE HLDGS COM 58506Q109 3,027,018 -388,209 -11.37 475,756 -6.93 0.0162
2022-08-12 2022-06-30 13F MEDPACE HLDGS COM 58506Q109 3,415,227 -377,467 -9.95 511,158 -17.61 0.0164
2022-05-12 2022-03-31 13F MEDPACE HLDGS COM 58506Q109 3,792,694 35,121 0.93 620,448 -24.13 0.0167
2022-02-10 2021-12-31 13F MEDPACE HLDGS COM 58506Q109 3,757,573 3,507 0.09 817,797 15.09 0.0208
2021-11-09 2021-09-30 13F MEDPACE HLDGS COM 58506Q109 3,754,066 37,926 1.02 710,567 8.26 0.0199
2021-08-11 2021-06-30 13F MEDPACE HLDGS COM 58506Q109 3,716,140 -154,008 -3.98 656,381 3.38 0.0183
2021-05-07 2021-03-31 13F MEDPACE HLDGS COM 58506Q109 3,870,148 78,980 2.08 634,899 20.31 0.0187
2021-02-05 2020-12-31 13F MEDPACE HLDGS COM 58506Q109 3,791,168 185,800 5.15 527,731 30.98 0.0168
2020-11-06 2020-09-30 13F MEDPACE HLDGS COM 58506Q109 3,605,368 -985,805 -21.47 402,901 -5.66 0.0149
2020-08-14 2020-06-30 13F MEDPACE HLDGS COM 58506Q109 4,591,173 51,651 1.14 427,071 28.21 0.0170
2020-05-01 2020-03-31 13F MEDPACE HLDGS COM 58506Q109 4,539,522 -149,593 -3.19 333,111 -15.49 0.0163
2020-02-13 2019-12-31 13F MEDPACE HLDGS COM 58506Q109 4,689,115 91,055 1.98 394,168 2.01 0.0151
2019-11-08 2019-09-30 13F MEDPACE HLDGS COM 58506Q109 4,598,060 59,455 1.31 386,420 30.15 0.0162
2019-08-22 2019-06-30 13F/A-1 MEDPACE HLDGS COM 58506Q109 4,538,605 406,428 9.84 296,914 21.85 0.0127
2019-08-13 2019-06-30 13F MEDPACE HLDGS COM 58506Q109 4,538,605 406,428 296,914
2019-05-09 2019-03-31 13F MEDPACE HLDGS COM 58506Q109 4,132,177 -26,182 -0.63 243,675 10.71 0.0109
2019-02-08 2018-12-31 13F MEDPACE HLDGS COM 58506Q109 4,158,359 1,876,296 82.22 220,103 60.99 0.0111
2018-11-09 2018-09-30 13F MEDPACE HLDGS COM 58506Q109 2,282,063 676,396 42.13 136,719 98.02 0.0059
2018-08-09 2018-06-30 13F MEDPACE HLDGS COM 58506Q109 1,605,667 392,792 32.39 69,043 63.06 0.0032
2018-05-09 2018-03-31 13F MEDPACE HLDGS COM 58506Q109 1,212,875 87,897 7.81 42,342 3.80 0.0020
2018-02-09 2017-12-31 13F MEDPACE HLDGS COM 58506Q109 1,124,978 648,204 135.96 40,793 168.22 0.0019
2017-11-14 2017-09-30 13F MEDPACE HLDGS COM 58506Q109 476,774 -5,235 -1.09 15,209 8.81 0.0008
2017-08-10 2017-06-30 13F MEDPACE HLDGS COM 58506Q109 482,009 -105,122 -17.90 13,978 -20.25 0.0007
2017-05-12 2017-03-31 13F MEDPACE HLDGS COM 58506Q109 587,131 581,123 9,672.49 17,527 7,976.96 0.0010
2017-02-10 2016-12-31 13F MEDPACE HLDGS COM 58506Q109 6,008 6,008 217 0.0003
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.